Your browser doesn't support javascript.
loading
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.
Antonarakis, Emmanuel S; Piulats, Josep M; Gross-Goupil, Marine; Goh, Jeffrey; Ojamaa, Kristiina; Hoimes, Christopher J; Vaishampayan, Ulka; Berger, Ranaan; Sezer, Ahmet; Alanko, Tuomo; de Wit, Ronald; Li, Chunde; Omlin, Aurelius; Procopio, Giuseppe; Fukasawa, Satoshi; Tabata, Ken-Ichi; Park, Se Hoon; Feyerabend, Susan; Drake, Charles G; Wu, Haiyan; Qiu, Ping; Kim, Jeri; Poehlein, Christian; de Bono, Johann Sebastian.
Afiliación
  • Antonarakis ES; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Piulats JM; Catalan Cancer Institute, Bellvitge Biomedical Research Institute, Centro de Investigación Biomédica en Red de Cáncer, Hospitalet de Llobregat, Barcelona, Spain.
  • Gross-Goupil M; Institut Bergonié, Bordeaux, France.
  • Goh J; Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Ojamaa K; University of Queensland, St Lucia, QLD, Australia.
  • Hoimes CJ; East Tallinn Central Hospital, Tallinn, Estonia.
  • Vaishampayan U; Case Comprehensive Cancer Center at University Hospitals Seidman Cancer Center, Cleveland, OH.
  • Berger R; Karmanos Cancer Institute, Wayne State University, Detroit, MI.
  • Sezer A; Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Alanko T; Baskent University Hospital Adana, Adana, Turkey.
  • de Wit R; Docrates Cancer Center, Helsinki, Finland.
  • Li C; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Omlin A; Karolinska Institutet, Stockholm, Sweden.
  • Procopio G; Cantonal Hospital St Gallen, University of Bern, Bern, Switzerland.
  • Fukasawa S; Fondazione Istituto Nazionale Tumori, Milan, Italy.
  • Tabata KI; Chiba Cancer Center, Chiba, Japan.
  • Park SH; Kitasato University, Kanagawa, Japan.
  • Feyerabend S; Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea.
  • Drake CG; Studienpraxis Urologie, Nürtingen, Germany.
  • Wu H; New York Presbyterian/Columbia University Medical Center, New York, NY.
  • Qiu P; MSD China, Beijing, China.
  • Kim J; Merck & Co, Kenilworth, NJ.
  • Poehlein C; Merck & Co, Kenilworth, NJ.
  • de Bono JS; Merck & Co, Kenilworth, NJ.
J Clin Oncol ; 38(5): 395-405, 2020 02 10.
Article en En | MEDLINE | ID: mdl-31774688
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Moldova
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Moldova